You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

SULFACEL-15 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Sulfacel-15 patents expire, and when can generic versions of Sulfacel-15 launch?

Sulfacel-15 is a drug marketed by Optopics and is included in one NDA.

The generic ingredient in SULFACEL-15 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sulfacel-15

A generic version of SULFACEL-15 was approved as sulfacetamide sodium by SANDOZ on October 18th, 1988.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SULFACEL-15?
  • What are the global sales for SULFACEL-15?
  • What is Average Wholesale Price for SULFACEL-15?
Summary for SULFACEL-15
Drug patent expirations by year for SULFACEL-15

US Patents and Regulatory Information for SULFACEL-15

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Optopics SULFACEL-15 sulfacetamide sodium SOLUTION/DROPS;OPHTHALMIC 080024-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.